<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04796129</url>
  </required_header>
  <id_info>
    <org_study_id>2020/329</org_study_id>
    <nct_id>NCT04796129</nct_id>
  </id_info>
  <brief_title>Correlation of the Inflammatory Parameters With Pain and Radiological Findings in Coxarthrosis</brief_title>
  <official_title>Evaluation of the Correlation of the Inflammatory Parameters With Pain and Radiological Findings in Patients With Coxarthrosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kanuni Sultan Suleyman Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Abant Izzet Baysal University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Istanbul University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Osteoarthritis (OA) is a functional disease with joint degeneration with subchondral and&#xD;
      periosteal lesions. Coxarthrosis (or hip osteoarthritis) is an important cause of disability,&#xD;
      especially in the advanced age group.Although hip osteoarthritis is often thought to be a&#xD;
      non-inflammatory pathology, recent studies have shown that joint degeneration is correlated&#xD;
      with the production of inflammatory factors and cartilage destroying enzymes.&#xD;
&#xD;
      There are very few studies evaluating the correlation of Neutrophil lymphocyte ratio,&#xD;
      monocyte lymphocyte ratio and Platelet lymphocyte ratio with inflammatory parameters CRP and&#xD;
      ESR levels in hip osteoarthritis and its relation with the staging of hip osteoatritis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Osteoarthritis (OA) is a disease characterized by joint degeneration with subchondral and&#xD;
      periosteal lesions . Coxarthrosis (hip osteoarthritis) is an important cause of disability,&#xD;
      especially in the advanced age group. The risk of symptomatic coxarthrosis in persons up to&#xD;
      the age of 85 is approximately 25%. There is a possibility of total hip replacement at a rate&#xD;
      of approximately 10% due to advanced stage coxarthrosis. Kellgren-Lawrence staging system is&#xD;
      used to show disease severity in osteoarthritis staging. According to this, Stage 0: there is&#xD;
      no radiological change, Stage 1: there is a slight narrowing in the joint space, Stage 2:&#xD;
      osteophytes are formed in the joint space with stenosis in the anteroposterior radiography,&#xD;
      Stage 3: multiple osteophytes, significant narrowing of the joint space, sclerosis and Stage&#xD;
      4 It describes a situation accompanied by large osteophytes, severe stenosis in the joint&#xD;
      space, prominent sclerosis, and bone deformities.&#xD;
&#xD;
      Although coxarthrosis is often thought to be a non-inflammatory pathology, recent studies&#xD;
      have shown that joint degeneration correlates with the production of inflammatory factors and&#xD;
      cartilage destroying enzymes. At the cellular level, it has been found that macrophage and&#xD;
      perivascular T and B lymphocyte infiltration play a role in early and advanced stage OA.&#xD;
&#xD;
      Neutrophils and lymphocytes are the main determinants of the inflammatory process. The&#xD;
      neutrophil to lymphocyte ratio (NLR) is obtained by dividing the absolute neutrophil count by&#xD;
      the number of lymphocytes obtained from the peripheral blood count. They are used as an&#xD;
      indicator of the inflammatory process in inflammatory conditions such as ankylosing&#xD;
      spondylitis, sarcoidosis, and cancers. In addition, platelet lymphocyte ratio (PLR) has also&#xD;
      been found to be associated with disease activity and severity in diseases such as rheumatoid&#xD;
      arthritis and psoriatic arthritis. Its use in the diagnosis and follow-up of OA has not yet&#xD;
      been clearly demonstrated. However, changes in mean platelet volume are also used as an&#xD;
      indicator of disease severity in systemic inflammatory diseases.&#xD;
&#xD;
      There are very few studies evaluating the correlation of Neutrophil lymphocyte ratio,&#xD;
      monocyte lymphocyte ratio and Platelet lymphocyte ratio with inflammatory parameters CRP and&#xD;
      ESR levels in hip osteoarthritis and its relation with the staging of hip osteoatritis. The&#xD;
      aim of this study to evaluate of the correlation of the inflammatory parameters with pain and&#xD;
      radiological findings in the patients with coxarthrosis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 11, 2021</start_date>
  <completion_date type="Anticipated">November 11, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 11, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Visual Analog Scale</measure>
    <time_frame>1 day</time_frame>
    <description>pain of the hip joints of the participants. It will be evaluated by using Visual Analog Scale(VAS). The scale is a unidimensional measure of pain intensity, which has been widely used in diverse adult populations. The pain range is from 1 to 10. The minimum value is 1 and it means the pain is so mild. The maximum value is 10, it means the pain is so much, like a knife stabs.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>NLR</measure>
    <time_frame>1day</time_frame>
    <description>neutrophil lymphocyte ratio</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PLR</measure>
    <time_frame>1 day</time_frame>
    <description>platelet lymphocyte ratio</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MLR</measure>
    <time_frame>1 day</time_frame>
    <description>monocyte lymphocyte ratio</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ESR</measure>
    <time_frame>1 day</time_frame>
    <description>Erythrocyte Sedimentation Ratio</description>
  </primary_outcome>
  <primary_outcome>
    <measure>CRP</measure>
    <time_frame>1 day</time_frame>
    <description>C-reactive protein</description>
  </primary_outcome>
  <primary_outcome>
    <measure>X-ray of hip joints</measure>
    <time_frame>1 day</time_frame>
    <description>an AP X-ray for the painful hip joints</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lequesne Index</measure>
    <time_frame>1 day</time_frame>
    <description>pain severity</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">132</enrollment>
  <condition>Osteoarthritis, Hip</condition>
  <condition>Inflammation</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>patients with hip osteoarthritis</arm_group_label>
    <description>the patients who aged 45 and older and have paint in the hips. and also without having any other comorbidities about inflammatory status.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <description>the participants who have any other comorbidities for impact on the inflammatory status and also no hip pain.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>the patients with hip osteoarthritis and their inflammatory status</intervention_name>
    <description>The participants in the experimental group will be evaluated for the hip osteoarthritis. They will take and X-ray for hip joints and also hemogram for the excluding the inflammatory diseases.</description>
    <arm_group_label>control</arm_group_label>
    <arm_group_label>patients with hip osteoarthritis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        the participants in the experimental group are at aged 45 years or older and have hip&#xD;
        osteoarthritis the participants in the control group are at aged 45 years or older and have&#xD;
        no any other diseases that effect the inflammatory status&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Being diagnosed with hip osteoarthritis&#xD;
&#xD;
          -  Being aged at 45 years or older&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Not accept being participation in the study.&#xD;
&#xD;
          -  Having any systemic disease like the diabetes mellitus, hypertension, coronary after&#xD;
             disease&#xD;
&#xD;
          -  Having any inflammatory rheumatologic disease&#xD;
&#xD;
          -  Having any disease that prevent to participate the study like mental retardation,&#xD;
             dementia and psychotic disorders.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Merve Damla Korkmaz, 1</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istanbul University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Merve Damla Korkmaz, 1</last_name>
    <phone>+905556297264</phone>
    <email>mervedml@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elif Yak≈üi, 2</last_name>
    <phone>+905069078505</phone>
    <email>elifyaksi@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kanuni Sultan Suleyman Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34303</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Merve Damla Korkmaz</last_name>
      <phone>+905556297264</phone>
      <email>mervedml@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Elif Yaksi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>February 10, 2021</study_first_submitted>
  <study_first_submitted_qc>March 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2021</study_first_posted>
  <last_update_submitted>August 24, 2021</last_update_submitted>
  <last_update_submitted_qc>August 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul University</investigator_affiliation>
    <investigator_full_name>Merve Damla Korkmaz</investigator_full_name>
    <investigator_title>Principle investigator</investigator_title>
  </responsible_party>
  <keyword>hip osteoarthritis</keyword>
  <keyword>inflammation</keyword>
  <keyword>pain severity</keyword>
  <keyword>pain level</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Hip</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>all IPD that underlie results in a publication)</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>The data will be available after publication</ipd_time_frame>
    <ipd_access_criteria>The data will share with permission and request.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

